Audit of 1 year survival for patients receiving chemotherapy for NSCLC - all comers

被引:0
|
作者
Allison, J. L. E. [1 ]
Lord, H. [2 ]
机构
[1] NHS Tayside, Med Oncol, Dundee, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, NHS Tayside, Oncol, Dundee DD1 9SY, Scotland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
81
引用
收藏
页码:S29 / S29
页数:1
相关论文
共 50 条
  • [11] Rate of neutropenic sepsis in relapsed NSCLC patients receiving docetaxel chemotherapy
    Gyi, M. M.
    Gulliford, T. J.
    Muthuramalingam, S. R.
    LUNG CANCER, 2017, 103 : S41 - S42
  • [12] Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy
    Weissferdt, Annikka
    Pataer, Apar
    Vaporciyan, Ara A.
    Correa, Arlene M.
    Sepesi, Boris
    Moran, Cesar A.
    Wistuba, Ignacio I.
    Roth, Jack A.
    Shewale, Jitesh Baban
    Heymach, John, V
    Kalhor, Neda
    Cascone, Tina
    Hofstetter, Wayne L.
    Lee, J. Jack
    Swisher, Stephen G.
    CLINICAL LUNG CANCER, 2020, 21 (04) : 341 - 348
  • [13] Renal function in patients receiving chemotherapy: Impact on survival
    Thibault, C.
    Duong, D. K.
    Scotte, F.
    Rance, B.
    Bouchouicha, A.
    Oudard, S.
    Elaidi, R. T.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S241 - S242
  • [14] An audit of ultrasound-assisted catheter insertion in patients receiving chemotherapy
    Shabbir, J
    Kallimutthu, SG
    O'Sullivan, JB
    Nisar, A
    Kavanagh, EG
    Burke, PE
    Grace, PA
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2005, 3 (01): : 32 - 35
  • [15] The effect of pain on survival in non-small cell lung cancer (NSCLC) patients with bone metastases receiving chemotherapy
    Yoh, K.
    Kubota, K.
    Ohmatsu, H.
    Goto, K.
    Niho, S.
    Nishiwaki, Y.
    Saijo, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [16] A retrospective analysis of Impella use in all-comers: 1-year outcomes
    Lazkani, Mohamad
    Murarka, Shishir
    Kobayashi, Akihiro
    Seibolt, Luke
    Yang, Tae
    Pershad, Ashish
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2017, 30 (06) : 577 - 583
  • [17] CYFRA 21-1 As a Predictor to Response to Chemotherapy and Overall Survival in Patients with Advanced NSCLC
    Lqbal, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S884 - S884
  • [18] Five-Year Survival and Complications of Thoracic Endovascular Aortic Repair (TEVAR): A Single Tertiary Center Registry for All-Comers Patients
    Haji-Zeinali, Ali Mohammad
    Mansouri, Pejman
    Hosseini, Neda Raeis
    Abbasi, Kiomars
    Shirzad, Mahamoud
    Jameie, Mana
    Haji-Zeinali, Mohammad Mohsen
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2023, 51 : 23 - 30
  • [19] What Factors Determine Treatment Satisfaction in Patients with Advanced NSCLC Receiving Chemotherapy?
    Visser, Sabine
    De Mol, Mark
    Van Walree, Nico
    Van Toor, Jermo
    Den Oudsten, Brenda
    Stricker, Bruno
    Aerts, Joachim
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S673 - S674
  • [20] Satisfaction with Therapy and the Relation with Quality of Life in Patients with Advanced NSCLC Receiving Chemotherapy
    Visser, Sabine
    De Mol, Mark
    Cheung, C.
    Van Walree, Nico
    Van Toor, Jermo
    Den Oudsten, B. L.
    Stricker, Bruno
    Aerts, Joachim G.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S317 - S317